Contribution of Blood Phosphate Esters to the Blood Saccharoid Fraction of Rats with Alloxan-induced Diabetes or Treated with Insulin or Epinephrine
Zeenat-un-Nisa and M. Ataur Rahman'
Nonglucose reducing substances in blood Constitute the "saccharoid fraction," which increases both in hyperand hypoglycemia.
The phosphate esters, including weak-acid phosphates and fructose-i ,6-diphosphate, constitute 14 to 25% of the saccharoid fraction in whole blood, 2 to 9% in plasma, and 24 to 35% in erythrocytes of normal rats treated with insulin or epinephrine and of alloxan diabetic rats treated with insulin. Glutathione, glucuronic acid, ascorbic acid, uric acid, and creatinine (reported earlier) and the phosphate esters (reported here) altogether account for 75 to 100% of the saccharoid fraction under the experimental conditions used, except in the alloxan-diabetic rats, where on the fourth day of alloxan treatment a larger proportion was unaccounted for. The dynamic character of the saccharoid fraction is probably due to the evanescent nature of these phosphate esters. The esters of phosphorus-including hexose phosphates, glyceraldehyde phosphate, and nucleotidesare more plentiful in the cells than in the plasma, in which they are found in only small amounts (6 Their contribution to the saccharoid fraction was also calculated.
Materials and Methods

Sampling
Procedure
The experiments were carried out on male albino animals were allowed access to food and water within a few minutes after the injection of alloxan. Two days after alloxan treatment, one group of animals received physiological saline, while the other group was fasted overnight and injected subcutaneously with 4 units of soluble insulin. Blood samples were collected from the overnight-fasted animals percutaneously from the heart at timed intervals after stunning the' animal by a blow on the head. Potassium oxalate solution (300 g/liter, adjusted to pH 7.4) (6) was used as the anticoagulant.
For 10 ml of blood, 0.1 ml of anticoagulant (spread on the walls of the tube and dried) was used. Blood from three animals was pooled to collect the erythrocytes.
The erythrocytes were isolated by immediately centrifuging the oxalated blood for 10 mm at 3500 rpm at 4 #{176}C. Supernatant plasma and buffy coat were aspirated and the cells were resuspended in about 5 volumes of ice-cold saline and centrifuged.
The saline and the top layer of cells were aspirated.
In the case of the diabetic group, the extent of dia- 
Results
The mean reducing capacity of phosphate esters is shown in Table 1 . Glucose-i-phosphate, AMP, ADP, ATP, MPG, 2,3-DPG, and NADP had no measurable reducing power. The highest reduction was obtained with glucose-6-phosphate.
Alloxan.
The total reducing substances and true glucose increased in whole blood, plasma, and erythnocyte on alloxan treatment ( (whole blood) decreased. Figure 1 shows the effect of alloxan on phosphate esters.
In whole blood and erythrocytes, the weakacid phosphorus increased gradually, reaching a maximum (P < .01) on the fourth and forty-ninth day of alloxan treatment.
Other phosphate compounds showed a maximum decrease on the fourth day of alloxan treatment.
Epinephrine and insulin.
There was a significant increase in total reducing substances, "true" glucose, and organic phosphorus in whole blood and erythrocytes (P < .01) in the first hour after epinephnine treatment, while plasma organic phosphorus remained unchanged ( 'le th bmri after th3ec.
substances, "true" glucose, nonprotein nitrogen, amino nitrogen, and inorganic phosphorus decreased significantly with simultaneous increase in organic phosphorus.
The total reducing substances, "true" glucose, and nonprotein nitrogen decreased after injection of insulin to alloxan diabetic rats. Two hours after insulin injection, inorganic phosphorus and amino-nitrogen were unaltered, while organic phosphorus was increased in whole blood (P < .05) and erythrocytes (P < .01). WAP increased significantly (P < .01) in plasma of normal rats 2 h after insulin treatment and 1 h after epinephrine injection ( Figure  2 ). There was no change in any other fractions except for ADP and MPG of erythrocytes, which gradually increased, the maximum (P < .01) being observed 2 h after insulin injection ( Figure 3 ). HDP fraction of plasma and erythrocytes increased (P < .05) 2 (Table 4) .
The recovery of saccharoid fraction as reported earlier (2) and of phosphate compounds as reported here shows that on the fourth day of alloxan treatment a larger portion remained unaccounted for. In whole blood, the percentage recovery of saccharoid fraction was significantly higher (P < .01) 3 h after insulin treatment of normal rats, while there was an increase (P < .01) in plasma and erythrocytes 2 h after injection (Table 5 ). In epinephnine-treated normal rats, the percentage recovery was higher in erythrocytes (P < .01) 1 and 2 h after injection. In insulin-treated alloxan-diabetic rats, there was a significant decrease (P < .01) in saccharoid fraction, with a simultaneous increase in the recovery as phosphate ester in whole blood and plasma 3 h after injection.
Discussion
The nonglucose reducing substances in blood are in a dynamic state. It was suggested earlier that re- (2, 4) . Some of the reducing sugar phosphates reported to be normal constituents of saccharoid fraction are insulin responsive (3) . Of the phosphate esters tested by the Folin-Wu method, and expressed as glucose equivalents (Table 1) the reduction attributable to WAP, we used the mean reducing power of HMP ( Table 1 ). The phosphate esters are more plentiful in cells than in plasma (6) . Inorganic phosphorus in blood, plasma, and erythrocytes in the alloxan-diabetic rats was increased significantly (P < .01), with a simultaneous decrease in organic phosphorus. Alpha-amino nitrogen in alloxan-diabetic rats was decreased on the fourth day after treatment (Table 2 ). Sacks (13) reported that in the liver of alloxan diabetic rat, there was an increase of about 50% in the concentration of inorganic phosphate and decrease to about one-third in the concentration of ADP-ATP, glucose-i-phosphate and glucose-6-phosphate.
Kireeva (14) found that in comatose and precomatose patients, the higher the glycosuria and hyperglycemia, the lower was the concentration of amino acid nitrogen in the blood. The concentrations of several amino acids in plasma were also decreased in diabetic patients and the capacity of the diabetic liver to de-aminate amino acids and form glucose was greatly increased.
A marked decrease in all the fractions except WAP was observed on treatment with alloxan ( Figure 1 ). It has been postulated that there is decreased oxidative phosphorylation in diabetes, a moderate decrease in liver ATP, and an absolute increase in AMP; therefore ATP in the liver of diabetic animal may be ratelimiting (15) . In the control group (zero time, Table  3 ) the concentration of inorganic phosphorus in erythrocytes is less than that in plasma and whole blood. Low values for inorganic phosphorus in normal erythrocytes are considered to be a consequence of active metabolism rather than a result of minimal metabolic participation (16) . In normal rats, there was a significant decrease (P < .01) in the alphaamino nitrogen and nonprotein nitrogen 2 h after insulin treatment (Table 3) . These findings agree with those of Luck et al. (17) , who also reported that insulin decreases the concentration of amino acids in the blood of man, rabbit, and rat; this was attributed to an increased catabolic rate. On epinephrine treat- (Figure 3 ). Insulin stimulates glycolysis and causes an increased HMP content in blood. Shaw and Stadie (18) have reported that insulin increases the turnover rate of glucose-6-phosphate and glucose-i-phosphate.
NORMAL RATS
The phosphate esters usually showed an increase 2 h after insulin injection in diabetic rats ( Figures  2, 3 ). It appears likely that the action of insulin in the presence of abundant glucose may lead to a decreased intracellular pH as a result of the increased concentration of sugar phosphates, which are stronger acids than is phosphoric acid (19) .
Insulin also restores the ability of the diabetic liver to utilize glucose (20) .
Although both the saccharoid fraction and the portion of it that was unaccounted for increased at the fourth day of alloxan treatment, the percentage recovery of saccharoid fraction as nitrogenous compounds (2) and as phosphate esters was decreased on that day (Table 4 ). This portion may consist of substances that ordinarily do not contribute to the saccharoid fraction.
In erythrocytes and plasma of normal rats, 2 h after insulin injection, the recovery of saccharoid fraction was maximum as compared to whole blood, where the percentage recovery was increased 3 h after injection (Table 5 ). Changes in the saccharoid fraction sum to parallel those in glucose concentration of whole blood or plasma in insulin-treated diabetic rats 2 and 3 h after injection. In erythrocytes, although the sugar values were decreased, there was no change in the saccharoid fraction. The action of insulin on saccharoid fraction in normal and diabetic rats is different and, therefore, the two saccharoid fractions perhaps consist of two different types of substances.
In the insulin-treated normal rats, practically all the saccharoid fraction was accounted for 3 h after insulin injection.
We found that, in rats, the WAP and fructose-i,6-diphosphate accounts for about 14 to 25% of the reducing substances in whole blood, 2 to 9% in plasma, and 24 to 35% of saccharoid fraction in erythrocytes (Tables  4 and 5 ). The recovered sccharoid fraction reported earlier (2) plus the phosphate esters reported here account for 75 to 100% in the experimental conditions studied, except in the alloxan-diabetic rats, for which, on the fourth day of alloxan treatment, 41% was not accounted for in whole blood.
